|
Multiple sclerosis
Citations 341-350 of 469 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
An improved ELISA for screening for neutralizing anti-IFN-ß antibodies in MS patients
- Andrew R. Pachner
Neurology 2003; 61: 1444-1446.
[Abstract]
[Full text]
[PDF]
- ARTICLES
 B-Crystallin genotype has impact on the multiple sclerosis phenotype
- T. van Veen, L. van Winsen, J. B.A. Crusius, N. F. Kalkers, F. Barkhof, A. S. Peña, C. H. Polman, and B. M.J. Uitdehaag
Neurology 2003; 61: 1245-1249.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Multiple sclerosis presenting as lower motor neuron wasting and weakness of the distal upper extremity
- P. Siao Tick Chong, S. Vucic, and D. P. Cros
Neurology 2003; 61: 1303-a-1304-a.
[Full text]
[PDF]
- EDITORIALS
Environmental risk factors in multiple sclerosis: Causes, triggers, and patient autonomy
- Gary M. Franklin and Lorene Nelson
Neurology 2003; 61: 1032-1034.
[Full text]
[PDF]
- ARTICLES
Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis
- David Pitt, Iris E. Nagelmeier, Heather C. Wilson, and Cedric S. Raine
Neurology 2003; 61: 1113-1120.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Smoking is a risk factor for multiple sclerosis
- Trond Riise, Monica W. Nortvedt, and Alberto Ascherio
Neurology 2003; 61: 1122-1124.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Accuracy of clinical detection of INO in MS: Corroboration with quantitative infrared oculography
- T. C. Frohman, E. M. Frohman, P. O’Suilleabhain, A. Salter, R. B. Dewey, Jr., N. Hogan, S. Galetta, A. G. Lee, D. Straumann, J. Noseworthy, D. Zee, J. Corbett, J. Corboy, V. M. Rivera, and P. D. Kramer
Neurology 2003; 61: 848-850.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Fatigue in MS is related to sympathetic vasomotor dysfunction
- P. Flachenecker, A. Rufer, I. Bihler, C. Hippel, K. Reiners, K.V. Toyka, and J. Kesselring
Neurology 2003; 61: 851-853.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Is multiple sclerosis still a clinical diagnosis?
- Jack H. Simon and Alan J. Thompson
Neurology 2003; 61: 596-597.
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Botulinum toxin treatment of painful tonic spasms in multiple sclerosis
- D. A. Restivo, M. Tinazzi, F. Patti, A. Palmeri, and D. Maimone
Neurology 2003; 61: 719-a-720-a.
[Full text]
[PDF]
|
|
